VACCINE

Markets split between costly AI and undervalued sectors. Vaccine makers offer cheap valuations and steady income amid uncertainty.

Fund manager James McDonald at the Pengana High Conviction Equities Fund provides insight into some of the current opportunities arising for the Fund. In particular,...

When receiving my jab last month (thank you nurses at RBWH in Brisbane for your excellent care!) I couldn’t help wondering how much all these vaccines were costing....

Google searches for “inflation” are higher now than at any time since such things were first measured around 13 years ago. It’s partly a natural reaction to the...

Coolabah has attempted to forecast both the advent of "herd immunity" in Australia and when governments will be comfortable opening-up our borders to both inflows and...

There have really been three key phases to investment markets over the last year: the chaos at the start of the pandemic, followed by the incredible financial...

The psychologists call it middle child syndrome. The firstborn gets the responsibilities and privileges. The youngest is the over-indulged baby. But what about the...

Morgan Stanley has a decidedly bullish view on the trajectory of the global economy and, by extension, markets for 2021. We view 2021 as the start of a...

The global response to COVID-19 has been nothing short of a technological revolution in the healthcare sector. Perhaps most remarkable has been the speed with which...

Defying, at least temporarily, its defensive characteristics, listed property valuations in 2020 and 2021 responded to many of the same pandemic-linked stimuli as...